Impact Of Aerobic Exercise On Reduction Of Symptoms Of Polycystic Ovarian Syndrome Among Young Women With PCOS
Keywords:
Polycystic Ovarian Syndrome, aerobic exercise, menstrual irregularities, BMI, WHR, Hirsutism, young women, intervention studyAbstract
Background: In young women, polycystic ovary syndrome (PCOS) is prevalent; the condition affects metabolic balance, causes abnormal menstrual cycles, and increases androgenism, all of which have a negative effect on quality of life. A promising non-pharmacological strategy for the relief of polycystic ovary syndrome (PCOS) symptoms is aerobic exercise.
Objective: The goals of this research were to determine the pre-intervention health status of PCOS in young women, design an individualised aerobic exercise program, and then measure the results in terms of symptom reduction.
Methods: Forty women, diagnosed with polycystic ovary syndrome (PCOS) according to the Rotterdam criteria, between the ages of 16 to 27 participated in a pre-post intervention trial. At baseline, we measured demographics information by, information sheet. We also looked for clinical signs such as irregular periods, body mass index, waist hip ratio and hirsutism. Using paired t-tests (p < 0.05), data from before and after the 12-week aerobic exercise program (3-5 sessions/week, 30-45 minutes, moderate intensity) were compared.
Results: post-intervention improvements were noted in menstrual regularity,BMI, WHR and Hirsutism (as measured by the Modified Ferriman-Gallwey score) .
Conclusion: The 12-week aerobic exercise program's effectiveness as a non-pharmacological approach to PCOS care was shown by the substantial reduction of symptoms experienced by young women with PCOS. More research is needed to determine the potential advantages and wider use of this program
Downloads
Metrics
References
Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, et al. Recom mendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril. 2018;110(3):364–79.
Rotterdam EA-SPCWG. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19–25.
Teede HJ, Hutchison SK, Zoungas S. The management of insulin resistance in polycystic ovary syndrome. Trends Endocrinol Metab. 2007;18(7):273–9.
Balen AH, Morley LC, Misso M, Franks S, Legro RS, Wijeyaratne CN, et al. The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance. Hum Reprod Update. 2016;22(6):687–708.
Stepto NK, Cassar S, Joham AE, Hutchison SK, Harrison CL, Goldstein RF, et al. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp. Hum Reprod. 2013;28(3):777–84.
Moran LJ, Strauss BJ, Teede HJ. Diabetes risk score in the diagnostic categories of polycystic ovary syndrome. Fertil Steril. 2011;95(5):1742–8.
Cassar S, Misso ML, Hopkins WG, Shaw CS, Teede HJ, Stepto NK. Insulin resistance in polycystic ovary syndrome: a systematic review and metaanalysis of euglycaemic-hyperinsulinaemic clamp studies. Hum Reprod. 2016;31(11):2619–31.
Moran LJ, Misso ML, Wild RA, Norman RJ. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syn drome: a systematic review and meta-analysis. Hum Reprod Update. 2010;16(4):347–63.
Banting LK, Gibson-Helm M, Polman R, Teede HJ, Stepto NK. Physical activity and mental health in women with polycystic ovary syndrome. BMC Womens Health. 2014;14(1):51
Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet. 2007;370(9590):851–8.
Clarke DM, Currie KC. Depression, anxiety and their relationship with chronic diseases: a review of the epidemiology, risk and treatment evidence. Med J Aust. 2009;190(7 Suppl):S54–60.
Farrell K, Antoni MH. Insulin resistance, obesity, infammation, and depression in polycystic ovary syndrome: biobehavioral mechanisms and interventions. Fertil Steril. 2010;94(5):1565–74.
Hollinrake E, Abreu A, Maifeld M, Van Voorhis BJ, Dokras A. Increased risk of depressive disorders in women with polycystic ovary syndrome. Fertil Steril. 2007;87(6):1369–76.
Mansson M, Holte J, Landin-Wilhelmsen K, Dahlgren E, Johansson A, Landen M. Women with polycystic ovary syndrome are often depressed or anxious-a case control study. Psychoneuroendocrinology. 2008;33(8):1132–8.
Cofey S, Bano G, Mason HD. Health-related quality of life in women with polycystic ovary syndrome: a comparison with the general population using the Polycystic Ovary Syndrome Questionnaire (PCOSQ) and the Short Form-36 (SF-36). Gynecol Endocrinol. 2006;22(2):80–6.
Banting LK, Gibson-Helm ME, Polman RE, Teede HJ, Stepto NK. Physical activity and mental health in women with Polycystic Ovary Syndrome. BMC Women’s Health. 2014;14(51).
Jones GL, Benes K, Clark TL, Denham R, Holder MG, Haynes TJ, et al. The Polycystic Ovary Syndrome Health-Related Quality of Life Questionnaire (PCOSQ): a validation. Hum Reprod. 2004;19(2):371–7.
Stephens T. Physical activity and mental health in the United States and Canada: Evidence from four population surveys. Prev Med. 1988;17(1):35–47.
Kirk AF, Higgins LA, Hughes AR, Fisher BM, Mutrie N, Hillis S, et al. A ran domized, controlled trial to study the efect of exercise consultation on the promotion of physical activity in people with Type 2 diabetes: a pilot study. Diabet Med. 2001;18(11):877–82.
Rippe JM, Price JM, Hess SA, Kline G, DeMers KA, Damitz S, et al. Improved psychological well-being, quality of life, and health practices in moder ately overweight women participating in a 12-week structured weight loss program. Obesity research. 1998;6(3):208–18
Conte F, Banting L, Teede HJ, Stepto NK. Mental health and physical activ ity in women with polycystic ovary syndrome: a brief review. Sports Med. 2015;45(4):497–504.
Thomson RL, Buckley JD, Lim SS, Noakes M, Clifton PM, Norman RJ, et al. Lifestyle management improves quality of life and depression in over weight and obese women with polycystic ovary syndrome. Fertil Steril. 2010;94(5):1812–6.
Vizza L, Smith CA, Swaraj S, Agho K, Cheema BS. The feasibility of progres sive resistance training in women with polycystic ovary syndrome: a pilot randomized controlled trial. BMC Sports Sci Med Rehabil. 2016;8:14.
Legro RS, Dodson WC, Kris-Etherton PM, Kunselman AR, Stetter CM, Williams NI, et al. Randomized Controlled Trial of Preconception Interventions in Infertile Women With Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2015;100(11):4048–58.
Patten RK, Boyle RA, Moholdt T, Kiel I, Hopkins WG, Harrison CL, et al. Exercise interventions in polycystic ovary syndrome: a systematic review and meta-analysis. Front Physiol. 2020;11(606).
Benham JL, Yamamoto JM, Friedenreich CM, Rabi DM, Sigal RJ. Role of exercise training in polycystic ovary syndrome: a systematic review and meta-analysis. Clinical obesity. 2018
Greenwood EA, Noel MW, Kao CN, Shinkai K, Pasch LA, Cedars MI, et al. Vigorous exercise is associated with superior metabolic profles in poly cystic ovary syndrome independent of total exercise expenditure. Fertil Steril. 2016;105(2):486–93.
Pokora K, Kowalczyk K, Wikarek A, et al. Depressive symptoms and control of emotions among Polish women with polycystic ovary syndrome. Int J Environ Res Public Health. 2022;19(24):16871.
Wright PJ, Dawson RM, Corbett CF. Social construction of biopsychosocial and medical experiences of women with polycystic ovary syndrome. J Adv Nurs. 2020;76(7):1728–1736
Wang G, Liu X, Zhu S, Lei J. Experience of mental health in women with polycystic ovary syndrome: a descriptive phenomenological study. J Psychosom Obstet Gynecol. 2023;44(1):2218987.
Rodriguez-Paris D, Remlinger-Molenda A, Kurzawa R, et al. Psychiatric disorders in women with polycystic ovary syndrome. Psychiatr Pol. 2019;53(4): 955–966.
Xing L, Xu J, Wei Y, et al. Depression in polycystic ovary syndrome: focusing on pathogenesis and treatment. Front Psychiatry. 2022;13:1001484.
Sidra S, Tariq MH, Farrukh MJ, Mohsin M. Evaluation of clinical manifestations, health risks, and quality of life among women with polycystic ovary syndrome. PLoS One. 2019;14(10):e0223329
Cowan S, Lim S, Alycia C, et al. Lifestyle management in polycystic ovary syndrome–beyond diet and physical activity. BMC Endocr Disord. 2023;23(1):14
Abdalla MA, Deshmukh H, Atkin S, Sathyapalan T. A review of therapeutic options for managing the metabolic aspects of polycystic ovary syndrome. Ther Adv Endocrinol Metab. 2020;11:2042018820938305.
Lee H, Lee S-H. Effectiveness of an integrated mobile application for lifestyle modifications in overweight women with polycystic ovarian syndrome: a randomized controlled trial. Life. 2023;13(7):1533.
Rao M, Khan AA, Adnan QUA. Effects of high-intensity interval training and strength training on levels of testosterone and physical activity among women with polycystic ovary syndrome. Obstet Gynecol Sci. 2022;65(4):368–375.
Shele G, Genkil J, Speelman D. A systematic review of the effects of exercise on hormones in women with polycystic ovary syndrome. J Funct Morphol Kinesiol. 2020;5(2):35.
Teede, H. J., et al. “Recommendations from the International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome.” Fertility and Sterility, vol. 110, 2018, pp. 364–379. https://doi.org/10.1016/j.fertnstert.2018.05.004.
Benham, J. L., et al. “Role of Exercise Training in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.” Clinical Obesity, 2018. https://doi.org/10.1111/cob.12258.
Haqq, L., et al. “The Effect of Lifestyle Intervention on Body Composition, Glycemic Control, and Cardiorespiratory Fitness in Polycystic Ovarian Syndrome: A Systematic Review and Meta-Analysis.” International Journal of Sport Nutrition and Exercise Metabolism, vol. 25, 2015, pp. 533–540. https://doi.org/10.1123/ijsnem.2013-0232.
Blair, S. N., et al. “Physical Fitness and All-Cause Mortality. A Prospective Study of Healthy Men and Women.” JAMA, vol. 262, 1989, pp. 2395–2401. https://doi.org/10.1001/jama.1989.03430170057028.
Barry, V. W., et al. “Fitness vs. Fatness on All-Cause Mortality: A Meta-Analysis.” Progress in Cardiovascular Diseases, vol. 56, 2014, pp. 382–390. https://doi.org/10.1016/j.pcad.2013.09.002.
Kodama, S., et al. “Cardiorespiratory Fitness as a Quantitative Predictor of All-Cause Mortality and Cardiovascular Events in Healthy Men and Women: A Meta-Analysis.” JAMA, vol. 301, 2009, pp. 2024–2035. https://doi.org/10.1001/jama.2009.681.
Harrison, C. L., et al. “The Impact of Intensified Exercise Training on Insulin Resistance and Fitness in Overweight and Obese Women with and without Polycystic Ovary Syndrome.” Clinical Endocrinology, vol. 76, 2012, pp. 351–357. https://doi.org/10.1111/j.1365-2265.2011.04160.x.
Lim, S. S., et al. “Overweight, Obesity and Central Obesity in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.” Human Reproduction Update, vol. 18, 2012, pp. 618–637. https://doi.org/10.1093/humupd/dms030.
Sprung, V. S., et al. “Exercise Training in Polycystic Ovarian Syndrome Enhances Flow-Mediated Dilation in the Absence of Changes in Fatness.” Medicine & Science in Sports & Exercise, vol. 45, 2013, pp. 2234–2242. https://doi.org/10.1249/MSS.0b013e31829ba9a1.
Thomson, R. L., et al. “The Effect of a Hypocaloric Diet with and without Exercise Training on Body Composition, Cardiometabolic Risk Profile, and Reproductive Function in Overweight and Obese Women with Polycystic Ovary Syndrome.” Journal of Clinical Endocrinology & Metabolism, vol. 93, 2008, pp. 3373–3380. https://doi.org/10.1210/jc.2008-0751.
Bruner, B., Chad, K., and D. Chizen. “Effects of Exercise and Nutritional Counseling in Women with Polycystic Ovary Syndrome.” Applied Physiology, Nutrition, and Metabolism, vol. 31, 2006, pp. 384–391. https://doi.org/10.1139/h06-007.
Rothman, K. J. “BMI-Related Errors in the Measurement of Obesity.” International Journal of Obesity, vol. 32, 2008, supplement S56. https://doi.org/10.1038/ijo.2008.87.
Janssen, I., Katzmarzyk, P. T., and R. Ross. “Waist Circumference and Not Body Mass Index Explains Obesity-Related Health Risk.” American Journal of Clinical Nutrition, vol. 79, 2004, pp. 379–384. https://doi.org/10.1093/ajcn/79.3.379.
Dunaif, A., et al. “Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome.” Diabetes, vol. 38, 1989, pp. 1165–1174. https://doi.org/10.2337/diab.38.9.1165.
Tosi, F., Bonora, E., and P. Moghetti. “Insulin Resistance in a Large Cohort of Women with Polycystic Ovary Syndrome: A Comparison Between Euglycaemic-Hyperinsulinaemic Clamp and Surrogate Indexes.” Human Reproduction, vol. 32, 2017, pp. 2515–2521. https://doi.org/10.1093/humrep/dex308.
Holten, M. K., et al. “Strength Training Increases Insulin-Mediated Glucose Uptake, GLUT4 Content, and Insulin Signaling in Skeletal Muscle in Patients with Type 2 Diabetes.” Diabetes, vol. 53, 2004, pp. 294–305. https://doi.org/10.2337/diabetes.53.2.294.
Pattyn, N., et al. “Aerobic Interval Training vs. Moderate Continuous Training in Coronary Artery Disease Patients: A Systematic Review and Meta-Analysis.” Sports Medicine, vol. 44, 2014, pp. 687–700. https://doi.org/10.1007/s40279-014-0158-x.
Greenwood, E. A., et al. “Vigorous Exercise Is Associated with Superior Metabolic Profiles in Polycystic Ovary Syndrome Independent of Total Exercise Expenditure.” Fertility and Sterility, vol. 105, 2016, pp. 486–493. https://doi.org/10.1016/j.fertnstert.2015.10.020.
Harrison, C. L., et al. “The Impact of Intensified Exercise Training on Insulin Resistance and Fitness in Overweight and Obese Women with and without Polycystic Ovary Syndrome.” Clinical Endocrinology, vol. 76, 2012, pp. 351–357. https://doi.org/10.1111/j.1365-2265.2011.04160.x.
DeFronzo, R. A., Tobin, J. D., and R. Andres. “Glucose Clamp Technique: A Method for Quantifying Insulin Secretion and Resistance.” American Journal of Physiology, vol. 237, 1979, pp. E214–E223. https://doi.org/10.1152/ajpendo.1979.237.3.E214
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
